
Description
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.
Team Members
Ryo Kubota
President and CEO
John Gebhart
CFO
Steve Tarr
COO
Ted Danse
CBO
Thomas Reh
Founder, Professor of Biological Structure, University of Washington